Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia, Myeloid, Acute 16Burkitt Lymphoma 15Leukemia, Myeloid, Accelerated Phase 10Blast Crisis 10Lymphoma, Mantle-Cell 8Congenital Abnormalities 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Non-Hodgkin 7Leukemia, Lymphocytic, Chronic, B-Cell 7Hodgkin Disease 7Hematologic Neoplasms 7Primary Myelofibrosis 6Myeloproliferative Disorders 6Multiple Myeloma 6Myelodysplastic Syndromes 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Biphenotypic, Acute 4Sezary Syndrome 3Recurrence 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large-Cell, Immunoblastic 3Breast Neoplasms 3Waldenstrom Macroglobulinemia 2

Interventions

Gemcitabine 11Cisplatin 11Nivolumab 4Doxorubicin 4pembrolizumab 3avelumab 3Radiotherapy 3Fluorouracil 3Docetaxel 3Carboplatin 3vinflunine 2pegfilgrastim 2Sunitinib 2Platinum 2Paclitaxel 2Immunoglobulin G 2Ifosfamide 2Disulfides 21,2-diaminocyclohexaneplatinum II citrate 2vandetanib 1tremelimumab 1tocilizumab 1temsirolimus 1tamibarotene 1relatlimab 1merphos 1guadecitabine 1enzalutamide 1durvalumab 1dehydroftorafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Urethral Neoplasms × merphos × Clear all
NCT01639521 2014-01-29

Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer

University of Southern California

Phase 2 Withdrawn
Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡